Puma Biotechnology (PBYI) PT Lowered to $87 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Buy the Puma Biotechnology (PBYI) Dip - Citi
May 10, 2018 12:32 PM EDTCiti analyst Yigal Nochomovitz came out to defend Puma Biotechnology (NASDAQ: PBYI), saying the sell-off is overdone and to buy the dip.
He said the Possible explanations in order of likelihood 1) Lower apparent demand (NRx / new specialty pharmacy pt adds) in April (~230 / 280) vs. March (~300 / 342), 2)... More
Puma Biotechnology (PBYI) PT Lowered to $111 at BofA/Merrill Lynch
May 10, 2018 6:28 AM EDTBofA/Merrill Lynch lowered its price target on Puma Biotechnology (NASDAQ: PBYI) to $111.00 (from $115.00) while maintaining a Buy rating.
... MorePuma Biotech (PBYI) Tops Q1 EPS by 24c
May 9, 2018 4:10 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q1 EPS of ($0.65), $0.24 better than the analyst estimate of ($0.89).
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
... More